Views on the current price and future of Pfizer $PFE?

Community

· Jun 10

The company is entering "the most important 18 months in Pfizer's history," CEO Bourla said in February. That's because the company plans to launch or expand the registration of 19 drugs over the next year and a half.

Those launches are expected to generate $20 billion in revenue by 2030, Bourla said. The group includes an RSV vaccine, elranatamab for multiple myeloma, ritlecitinib for alopecia areata and many other products.

Read more here 👇

Pfizer enters 'most important' stretch in company's history: CEO (fiercepharma.com)

A community member's personal view, not investment advice. Community Guidelines

Willard Spencer @willardspencer Jun 11

I guess it depends a lot if there's another pandemic coming or not... If so, I would definitely buy! :-D If not, this company is not interesting to me...

Bill Combs @billcombs Jun 11

I've been thinking about buying $PFE stock lately, as it's currently at a really nice price.

Ashraf Aboudar @ashraf_dd Jun 11

The price now is like it was before Covid, which probably makes a little sense. They had a vaccination for covid - the stock went up, now covid is gone and the stock is back...

Rickie Reeve @rickiereeve Jun 10

Super company at a super price. I like how they are trying to be groundbreaking with their new products. Like the recently mentioned anti-obesity drug.

Frazier Battle @frazierbattle Jun 10

Pfizer has a strong market position and these new products should help it grow dynamically. If all goes according to plan, Pfizer's stock price could easily double in the next 3-5 years, in my opinion. I'm holding them in my portfolio and will continue to buy.

Antony Earl @antonyearl Jun 10

Pfizer is a stable pharmaceutical company with a long history. If they manage to launch the planned 19 products, it should significantly boost their sales and profits in the coming years. Pfizer's stock could rise as a result. I have read many articles and studies on this topic and currently take PFE's stock price as a bargain.

⌘ K

StockBot Live

Market situation Global markets

Europe drops on French budget fears as US stocks rise

CAC 40 -1.02% and DAX -0.31% drop on French budget fears. S&P 500 +0.31% and Nasdaq +0.90% open higher on AI.

Ask about this

StockBot knows 80,000+ stocks worldwide